Tag: Clinical trial results

news-15102024-195147

Improved Survival in ES-SCLC with Lurbinectedin/Atezolizumab Combination

A combination of lurbinectedin and atezolizumab has shown significant benefits in overall survival (OS) and progression-free survival (PFS) for patients with extensive-stage small cell...
innovent-announces-data-from-pivotal-phase-2-trust-i-study-of-taletrectinibros1-inhibitor-are-published-in-the-jco-and-reported-at-2024-asco-annual-meeting-thailand-business-news

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib?ROS1 Inhibitor) are Published...

Innovent Biologics Reveals Breakthrough Data from Phase 2 TRUST-I Study of Taletrectinib at 2024 ASCO Annual MeetingSAN FRANCISCO, U.S. and SUZHOU, China - Innovent...

BREAKING NEWS

Random News

Most Read News